These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71. Role of angiotensin II in diabetic nephropathy. Leehey DJ; Singh AK; Alavi N; Singh R Kidney Int Suppl; 2000 Sep; 77():S93-8. PubMed ID: 10997697 [TBL] [Abstract][Full Text] [Related]
72. Critical role for osteopontin in diabetic nephropathy. Nicholas SB; Liu J; Kim J; Ren Y; Collins AR; Nguyen L; Hsueh WA Kidney Int; 2010 Apr; 77(7):588-600. PubMed ID: 20130530 [TBL] [Abstract][Full Text] [Related]
73. Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction. Rüster C; Franke S; Wenzel U; Schmidthaupt R; Fraune C; Krebs C; Wolf G Am J Nephrol; 2011; 34(4):309-17. PubMed ID: 21846974 [TBL] [Abstract][Full Text] [Related]
75. The role of angiotensin-II in progressive diabetic glomerulopathy in the rat. Whiteside CI; Thompson J Endocrinology; 1989 Oct; 125(4):1932-40. PubMed ID: 2551633 [TBL] [Abstract][Full Text] [Related]
76. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996 [TBL] [Abstract][Full Text] [Related]